Analyst Information

 

Edward Tenthoff

Sr Research Analyst

Edward Tenthoff

Ted Tenthoff is a managing director and senior research analyst at Piper Jaffray, focused on the drug discovery sector of the biotech industry. In April 2013 and 2015, Tenthoff moderated panels at the International Adult Stem Cell Conference at the Vatican. He was ranked No. 2 stock picker in biotechnology by the 2012 Wall Street Journal "Best on the Street" survey and was ranked No. 1 stock picker for the life science tools and services sector in the 2006 Starmine Analyst Awards. Prior to joining Piper Jaffray in 2003, he covered the genomics sector at Robertson Stephens & Company, and was a medical technology analyst at Lehman Brothers. Tenthoff received a bachelor's degree in international relations from the University of Pennsylvania.

Associates:

Jordyn Fantuzzi
Research Analyst
Kristin Ko, Ph.D.
Research Analyst
Universe Coverage:
Healthcare:   Biotechnology
ALNYAlnylam Pharmaceuticals, Inc.
ALPNAlpine Immune Sciences, Inc.
APVOAptevo Therapeutics Inc.
ARAVAravive, Inc.
ARGXargenx SE
ARWRArrowhead Pharmaceuticals
ARVNArvinas Inc.
ASLNAslan Pharmaceuticals Ltd.
AVEOAVEO Oncology, Inc.
BCYCBicycle Therapeutics Ltd.
CYADCelyad SA
CCXIChemoCentryx, Inc.
CHMAChiasma, Inc.
CFRXContraFect Corporation
CRSPCRISPR Therapeutics AG
CYTKCytokinetics, Incorporated
ELOXEloxx Pharmaceuticals, Inc.
EXELExelixis, Inc.
FATEFate Therapeutics, Inc.
KDS NAKiadis Pharma NV
MRKRMarker Therapeutics, Inc.
MISTMilestone Pharmaceuticals, Inc.
MRNAModerna, Inc.
NXTCNextCure, Inc.
ONCSOncoSec Medical Incorporated
PTIProteostasis Therapeutics, Inc.
SBPHSpring Bank Pharmaceuticals, Inc.
STROSutro Biopharma, Inc.
SYBXSynlogic, Inc.
SYRSSyros Pharmaceuticals, Inc.
VRTXVertex Pharmaceuticals Inc.
XNCRXencor, Inc.
ZFGNZafgen, Inc.